The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atracurium 10mg/ml Solution for Injection or Infusion

10 milligram(s)/millilitre Solution for injection

Hikma Farmaceutica (Portugal) SAPA1217/011/001

Main Information

Trade NameAtracurium 10mg/ml Solution for Injection or Infusion
Active SubstancesAtracurium besylate
Strength10 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderHikma Farmaceutica (Portugal) SA
Licence NumberPA1217/011/001

Group Information

ATC CodeM03AC Other quaternary ammonium compounds
M03AC04 atracurium


Licence Issued04/07/2014
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back